Hospital Acquired Infection Control Market – Global Forecast to 2026 with COVID-19 Impact Analysis – ResearchAndMarkets.com

DUBLIN – (COMMERCIAL THREAD) – The report “Hospital Acquired Infections Control Market Report 2021” has been added to ResearchAndMarkets.com offer.

The hospital acquired infection control market is expected to reach $ 31.3 billion by 2026, from $ 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period.

The growth of hospital acquired infection control market can be largely attributed to factors such as high incidence of hospital acquired infections, increasing number of surgeries, growing geriatric population and increasing incidence of chronic diseases, advancements in technology in sterilization equipment, and the growing awareness of environmental and personal hygiene due to COVID-19.

The growing use of electron beam sterilization, the reintroduction of ethylene oxide sterilization, the growth of the healthcare sector and the outsourcing of operations to emerging countries are expected to provide strong growth opportunities for players. of the market during the forecast period.

Currently, with the increase in cases of COVID-19, there is an increasing emphasis on personal hygiene as well as the increasing production of medical nonwovens and single-use products such as face masks and gloves. It is further expected to drive the growth of hospital acquired infection control market in the coming years.

On the other hand, concerns about the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of reprocessing endoscopes and limited reimbursement in developing countries and end-user non-compliance with sterilization standards, are expected to hold back the growth of this market.

The sterilization segment is expected to grow at the highest CAGR during the forecast period.

Based on the products and services used in hospital acquired infection control, the hospital acquired infection control market is segmented into sterilization, disinfectors, endoscope reprocessing products, disinfectants, protective barriers, and other infection control products. The sterilization segment is expected to grow at the highest CAGR during the forecast period.

This is attributed to the growing incidence of chronic diseases and pandemics (such as COVID-19), the growing need to reduce surgical site infections (SSI) and the growing number of surgeries being performed around the world. The increase in initiatives and regulatory actions by governments of various countries to strengthen hospitals with essential infection control standards to prevent the spread of HAIs is also expected to support the market growth.

The hospital and intensive care unit segment is expected to account for the largest share of the hospital-acquired infection control market.

On the basis of end user, the hospital acquired infection control market has been segmented into hospitals and intensive care units (ICUs), outpatient surgical and diagnostic centers, nursing homes and maternity units, and other users. final (dental clinics, trauma centers and laboratory clinics).

The hospital and intensive care unit segment accounted for the largest share of the hospital acquired infection control market in 2020. The growth of this market is mainly attributed to the increasing prevalence of HAIs, increasing adoption of medical devices for use. unique and growing number of surgeries around the world. .

Asia Pacific is expected to represent the highest CAGR for players operating in the hospital acquired infection control market.

The Asia-Pacific Hospital Acquired Infection Control market is expected to grow at the highest CAGR from 2021 to 2026. The bulk of the Hospital-Acquired Infection Control market growth is expected to come from emerging countries in the Asia-region. Peaceful. Growing number of surgeries performed each year, favorable government regulations, large patient population, and increasing incidence of COVID-19 are expected to drive the growth of the APAC market during the forecast period.

Premium previews

  • Growing Incidence of Hates and Rising Number of Surgical Procedures to Drive Market Growth

  • Hospitals and Critical Care Segment accounted for largest share of Asia-Pacific Hospital Acquired Infection Control Market in 2020

  • China To Record Highest Revenue Growth During Forecast Period

  • North America will continue to dominate the hospital acquired infection control market during the forecast period

  • Developing markets will register higher growth rate during the forecast period

Market dynamics

Market factors

  • High incidence of nosocomial infections (Hais)

  • Growing number of surgeries

  • Growing geriatric population and increasing incidence of chronic diseases

  • Technological advances in sterilization equipment

  • Growing awareness of environmental and personal hygiene due to COVID-19

Market constraints

  • Concerns about the safety of reprocessed instruments

  • Adverse effects of chemical disinfectants

  • High cost of endoscopic reprocessing and limited reimbursement in developing countries

Market opportunities

  • Reintroduction of ethylene oxide sterilization as a disinfectant in healthcare facilities

  • Growing adoption of nonwovens and single-use medical devices

  • Growth of the healthcare sector and outsourcing of operations to emerging countries

Market challenges

  • Complications Associated with Nosocomial Infection Control Procedures

  • End user non-compliance with sterilization standards

  • Development of alternative technologies for surface disinfection

Industry outlook

Industry trends

  • Increased adoption of sterilization using No2

  • Use of robotics for disinfection

  • Growing popularity of single-use products

  • Layering / bundling in infection prevention

Regulatory Analysis

  • Regulatory jurisdiction

  • By region

  • North America

  • we

  • Pre-market notification: 510 (K) approval for reprocessed medical devices

  • Canada

  • Europe

  • Ce marking for retired medical devices

  • Asia Pacific

  • Japan

  • Australia

  • Latin America

Policy for the application of sterilizers and disinfection devices during COVID-19

  • Sterilizers

  • Disinfection devices

Technological analysis

  • Key technologies

  • Complementary technologies

  • Adjacent technologies

Companies mentioned

  • 3M Company

  • Advanced Sterilization Products (ASP)

  • Belimed AG (subsidiary of the Metall Zug group)

  • Beta-Gamma-Service GmbH & Co. Kg

  • Blue Line LLC Sterilization Services

  • CBMSRL medical equipment

  • Contec, Inc.

  • Continental equipment company

  • Ecolab inc.

  • Getinge Ab

  • Matachana Group

  • Medalkan

  • Melag Medizintechnik GmbH & Co. Kg

  • Metrex Research LLC (a subsidiary of Danaher Corporation)

  • Midwestern Sterilization Society

  • Miele Group

  • MMM Group

  • Pal International

  • Reckitt Benckiser

  • Sotera Health Company

  • Steri-Tek

  • Sterilization services

  • Steripack Group

  • Steris plc

  • Systec GmbH

For more information on this report, visit https://www.researchandmarkets.com/r/wkswr8

About Linda Stewart

Linda Stewart

Check Also

Victim of a bullet in the leg in Winston-Salem, taken to hospital

WINSTON-SALEM, North Carolina (WGHP) – A victim was in the leg in Winston-Salem and taken …

Leave a Reply

Your email address will not be published. Required fields are marked *